4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-19-000226
EVP Strategy and Corporate Dev sold 1,532 shares at an average $152.37 ($233,435)
From the SEC's structured data for this filing
Trades in this filing
Pacelli Steven Robert · EVP Strategy and Corporate Dev
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-10-23 | Sale : show line 1 in the form | −641 | $151.69 | $97,236 | 81,642 | D |
| 2019-10-23 | Sale : show line 2 in the form | −681 | $152.71 | $103,997 | 80,961 | D |
| 2019-10-23 | Sale : show line 3 in the form | −210 | $153.34 | $32,202 | 80,751 | D |
| Open-market sales · 1,532 sh · avg $152.37 · $233,435 | ||||||
Loading xslF345X03/edgardoc.xml…